Consistent with these findings, our study observed that 24 of these genes showed increased expression in advanced fibrosis within our MASLD subgroups (Figure S2D), including five genes (STMN2, GDF15, LTBP2, ITGBL1, and THY1) that were differentially expressed in both F3 and F4 stages. The gene discussed is THY1; the disease is fibrosis.